Urologist-developed iPad app lets physicians illustrate medical conditions

Article

A new iPad application developed by urologic surgeons allows physicians to use detailed interactive imagery to illustrate and describe treatment options for medical conditions.

A new iPad application developed by urologic surgeons allows physicians to use detailed interactive imagery to illustrate and describe treatment options for medical conditions.

The app, called drawMD, was co-founded by urologists Todd Morgan, MD, and Alexander Kutikov, MD, and is sponsored by Boston Scientific. It is on display at Boston Scientific’s booths (2201 and 417) during this week’s AUA annual meeting.

With drawMD’s unique interface, physicians and patients can sketch, stamp, or type on top of detailed images to better understand and explain complex medical topics. Physicians can illustrate diagnoses, treatment plans, and urologic surgical procedures such as ureteroscopy and percutaneous nephrolithotomy. These illustrations can be e-mailed to patients and used as documentation in their medical records.

"This app lets patients have a visual guide and deeper understanding of their diagnosis and treatment options," Drs. Morgan and Kutikov said in a statement. "The drawMD application gives users the ability to reduce doctor-patient communication barriers by offering a new paradigm for explaining complex problems to patients-and even other physicians."

The drawMD app can be downloaded free of charge at www.drawMD.com or the iTunes app store.

Related Videos
DNA strands | Image Credit: ©  Matthieu - stock.adobe.com
Doctor consulting with patient | Image Credit: © Khunatorn - stock.adobe.com
Man talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Prostate cancer cell division | Image Credit: © PRB ARTS - stock.adobe.com
Keyan Salari, MD, PhD, answers a question during a Zoom video interview
Scott Morgan, MD, MSc, FRCPC, answers a question during a Zoom video interview
Illustration of prostate | Image Credit: © Judith - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.